To this aim, PBMCs from HIV+ and HIV− CHACS participants, with (TPV+) and without (TPV−) subclinical atherosclerosis, were analyzed for the composition of the pool of hematopoietic CD45+CD3+ T-cells (Figure S1). This evidence concerns the gene PTPRC and atherosclerosis.